Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeing Machines Regulatory News (SEE)

Share Price Information for Seeing Machines (SEE)

Share Price is delayed by 15 minutes
Get Live Data
4.32    -0.08 (-1.82%)
Bid:
4.35
Ask:
4.40
Spread: 0.05 (1.149%)
Market Cap: £207.34m
SEE Live PriceLast checked at - London Stock Exchange

Intraday Seeing Machines Share Chart

UK Fleet Contract

15 Jun 2017 07:00

RNS Number : 0487I
Seeing Machines Limited
15 June 2017
Β 

ο»Ώ

Β 

Β 

Seeing Machines Limited

("Seeing Machines" or "the Company")

Β 

Seeing Machines signs FreshLinc as first UK Fleet customer

Β 

15 June 2017

Β 

Seeing Machines (AIM: SEE), an industry leader in computer vision based human sensing technologies which enable breakthrough solutions in performance, safety and user experiences,Β announcesΒ its first UK multi-yearΒ servicesΒ contractΒ with FreshLinc, aΒ large temperature controlled distributor, subsequent to launching its Guardian System at the Commercial Vehicle Show in Birmingham, United Kingdom.

Β 

The Guardian System solution was successfully trialed at several of FreshLinc's depots to measure the levels of fatigue and distraction prevalent in their fleet and to evaluate the effectiveness of the Seeing Machines Guardian system at mitigating those risks through it's in-cabin alerts and 24/7 monitoring intervention service. The three-year agreement will see 320 of the distributor's heavy vehicles fitted with the Guardian System and the drivers further protected by the 24/7 global SafeGuard monitoring service based in Tucson, Arizona.

Β 

FreshLinc, already innovative in their approach to driver safety and compliance, are actively working with Seeing Machines to showcase the benefits gained through the deployment of Guardian across their fleet to other UK based distributors, driving superior safety solutions for the UK commercial vehicle industry and highways.

Β 

In 2015 1,804 people were killed and 22,855 people were seriously injured on the road in the UK. Of those accidents, distraction accounted for 25% of fatalities and driver error accounted for 68%, according to the Reported Road Casualties Great Britain: Annual report 2015, Department for Transport.

Β 

Seeing Machines'Β Guardian System is a real-time driver fatigue, distraction and accident prevention service, proven to achieve over 90% reduction in fatigue or distraction related driver events. As well as in-cabin alerts, such detected danger events are tracked and analysed in the 24/7 monitoring centre where tailored intervention programs and ongoing analytics are provided to fleet managers to help minimise incidents through ongoing driver training and wellness programs to keep drivers safe, prevent accidents and make roads safer.

Β 

PaulΒ Angelatos,Β President,Β GuardianΒ Systems at Seeing Machines commented: "The Guardian safety solution is already saving professional drivers' lives internationally, and now we're positioned to better protect UK fleet operators and surrounding highway users by addressing distracted driving and fatigue in real-time, preventing accidents before they happen. We are delighted to be working with FreshLinc to better safeguard their drivers, improve their safety culture and protect their brand."

Β 

Lee Juniper, Managing Director FreshLinc commented: "We care about our drivers and want to make sure each one gets home safely every day. Even though our drivers and equipment are among the best on-the-road, we are confident this technology will further strengthen our safety culture, protect our drivers and improve highway safety overall."

Β 

Β 

Enquiries:

Β 

Seeing Machines Limited

www.seeingmachines.comΒ  / +61 2 6103 4700

Mike McAuliffe, CEO

Mike.McAuliffe@seeingmachines.com

Media enquiries

Β 

Sophie.Nicoll@seeingmachines.com

finnCap Ltd

Ed Frisby / Emily Watts, Corporate Finance

+44 20 7220 0500

Tim Redfern / Richard Chambers, Corporate Broking

Canaccord Genuity Limited

Simon Bridges

+44 20 7423 8000

Antony Isaacs

Alexander Napier

Β 

Β 

About Seeing Machines

Β 

Seeing Machines, (AIM: SEE) is an industry leader in computer vision based human sensing technologies which enable breakthrough solutions in performance, safety and user experiences. With more than 15 years of R&D investment and proven industry experience, Seeing Machines uses advanced sensing technologies and machine learning algorithms to deliver precision tracking and analysis of heads, faces and eyes for multiple emerging applications. A primary application is Driver Monitoring Systems to detect and deal with drowsiness, distraction and further cognitive states which enables the "Guardian" Fleet safety product and intelligent ADAS / Autonomous Driving automotive solutions. A further key application is real-time delivery of precision eye tracking in real world vehicular conditions, normalizing for all light conditions (and challenges such as sunglasses) for smart display systems etc. The Company delivers its AI based technology platform in a range of solutions from embedded software to "Fovio" DMS processors to full systems such as the Guardian in-cabin and 24/7 monitoring and intervention telematics service for the commercial trucking sector, which prevents accidents and saves costs and lives. Seeing Machines' technology has been adopted by global industry leaders across the transportation spectrum such as Caterpillar in the off-road sector. Seeing Machines is headquartered in Canberra, Australia and currently has offices and people in Melbourne, Tucson, Silicon Valley, Detroit and UK.

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
NRAGRGDLXUBBGRS
Date   Source Headline
11th Jun 20099:12 amRNSDirector/PDMR Shareholding
21st May 20097:58 amRNSDirector Shareholding
11th Mar 20097:00 amRNSReviewed Interim Results
18th Feb 20097:00 amRNSRestructuring of the business
28th Jan 20099:41 amRNSTrading update and notice of results
1st Dec 20088:14 amRNSChange of Registered Office
27th Nov 20088:08 amRNSResult of AGM
29th Oct 200810:52 amRNSNotice of AGM
23rd Sep 20087:00 amRNSFinal Results
17th Sep 20088:37 amRNSNotice of Final Results
26th Aug 20088:33 amRNSNEW FACEAPI PRODUCT RELEASE
23rd Jul 20087:37 amRNSFirst Expected Profit Report
7th May 20088:08 amRNSNORTH AMERICAN OPERATION
7th Apr 200812:00 pmRNSChange of Broker
4th Mar 20087:59 amRNSInterim Results
4th Mar 20087:51 amRNSMajor contract gain
13th Feb 20088:27 amRNSHolding in Company
28th Dec 20079:11 amRNSAnnual Report
11th Dec 200710:54 amRNSChange of Adviser
29th Nov 200710:03 amRNSAGM Results
8th Nov 200712:38 pmRNSDirector/PDMR Shareholding
8th Nov 200712:34 pmRNSGlaucoma Device at AAO
31st Oct 20079:26 amRNSCompletion of Placing-Replace
31st Oct 20077:01 amRNSCompletion of Placing
26th Oct 20079:35 amRNSShareholder Approval
17th Oct 20072:21 pmRNSDirector/PDMR Shareholding
15th Oct 20079:23 amRNSCFO Appointment
25th Sep 200710:23 amRNSFurther Placing
24th Sep 20071:12 pmRNSFinal Results
24th Sep 20071:00 pmRNSFundraising
15th Aug 200712:43 pmRNSAIM Rule 26 Compliance
15th Aug 20079:27 amRNSFDA Approval for Truefield
2nd Jul 20077:01 amRNSNew Product Releases
29th Jun 200710:11 amRNSMaster License Agreement
22nd May 200711:15 amRNSLicensing agreement signed
8th May 20077:02 amRNSGlaucoma Device Demonstrated
28th Mar 20072:40 pmRNSInterim Results
14th Mar 200710:45 amRNSAward win for glaucoma device
12th Mar 20077:02 amRNSAddition to product released
19th Dec 200610:06 amRNSTotal Voting Rights
30th Nov 20068:27 amRNSAGM Statement
9th Nov 20067:01 amRNSGlaucoma Study Re-commences
2nd Nov 20067:01 amRNSNew Product
19th Oct 20065:38 pmRNSFinal Results - Replacement
19th Oct 200611:29 amRNSFinal Results
18th Oct 200611:04 amRNSDirectorate Change
17th Oct 20063:20 pmRNSNew Version of faceLAB
21st Sep 20064:41 pmRNSIssue of Equity
18th Sep 200611:24 amRNSAutomotive progress
18th Sep 20069:45 amRNSGlaucoma Grant Signed

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.